Literature DB >> 28809515

A Biosignature Predicting Complicated Course in Children Presenting with Septic Shock. Why PERSEVERE?

Adrienne G Randolph1,2,3.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28809515      PMCID： PMC5564677          DOI： 10.1164/rccm.201704-0759ED

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  15 in total

Review 1.  Biomarkers and surrogate endpoints: preferred definitions and conceptual framework.

Authors: 
Journal:  Clin Pharmacol Ther       Date:  2001-03       Impact factor: 6.875

Review 2.  What are biomarkers?

Authors:  Kyle Strimbu; Jorge A Tavel
Journal:  Curr Opin HIV AIDS       Date:  2010-11       Impact factor: 4.283

Review 3.  International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics.

Authors:  Brahm Goldstein; Brett Giroir; Adrienne Randolph
Journal:  Pediatr Crit Care Med       Date:  2005-01       Impact factor: 3.624

4.  PRISM III: an updated Pediatric Risk of Mortality score.

Authors:  M M Pollack; K M Patel; U E Ruttimann
Journal:  Crit Care Med       Date:  1996-05       Impact factor: 7.598

5.  Challenges in Biomarker Discovery: Combining Expert Insights with Statistical Analysis of Complex Omics Data.

Authors:  Jason E McDermott; Jing Wang; Hugh Mitchell; Bobbie-Jo Webb-Robertson; Ryan Hafen; John Ramey; Karin D Rodland
Journal:  Expert Opin Med Diagn       Date:  2013-01

6.  PELOD-2: an update of the PEdiatric logistic organ dysfunction score.

Authors:  Stéphane Leteurtre; Alain Duhamel; Julia Salleron; Bruno Grandbastien; Jacques Lacroix; Francis Leclerc
Journal:  Crit Care Med       Date:  2013-07       Impact factor: 7.598

7.  Pediatric Sepsis Biomarker Risk Model-II: Redefining the Pediatric Sepsis Biomarker Risk Model With Septic Shock Phenotype.

Authors:  Hector R Wong; Natalie Z Cvijanovich; Nick Anas; Geoffrey L Allen; Neal J Thomas; Michael T Bigham; Scott L Weiss; Julie Fitzgerald; Paul A Checchia; Keith Meyer; Michael Quasney; Mark Hall; Rainer Gedeit; Robert J Freishtat; Jeffrey Nowak; Shekhar S Raj; Shira Gertz; Kelli Howard; Kelli Harmon; Patrick Lahni; Erin Frank; Kimberly W Hart; Trung C Nguyen; Christopher J Lindsell
Journal:  Crit Care Med       Date:  2016-11       Impact factor: 7.598

8.  The pediatric sepsis biomarker risk model.

Authors:  Hector R Wong; Shelia Salisbury; Qiang Xiao; Natalie Z Cvijanovich; Mark Hall; Geoffrey L Allen; Neal J Thomas; Robert J Freishtat; Nick Anas; Keith Meyer; Paul A Checchia; Richard Lin; Thomas P Shanley; Michael T Bigham; Anita Sen; Jeffrey Nowak; Michael Quasney; Jared W Henricksen; Arun Chopra; Sharon Banschbach; Eileen Beckman; Kelli Harmon; Patrick Lahni; Christopher J Lindsell
Journal:  Crit Care       Date:  2012-10-01       Impact factor: 9.097

9.  Testing the prognostic accuracy of the updated pediatric sepsis biomarker risk model.

Authors:  Hector R Wong; Scott L Weiss; John S Giuliano; Mark S Wainwright; Natalie Z Cvijanovich; Neal J Thomas; Geoffrey L Allen; Nick Anas; Michael T Bigham; Mark Hall; Robert J Freishtat; Anita Sen; Keith Meyer; Paul A Checchia; Thomas P Shanley; Jeffrey Nowak; Michael Quasney; Arun Chopra; Julie C Fitzgerald; Rainer Gedeit; Sharon Banschbach; Eileen Beckman; Patrick Lahni; Kimberly Hart; Christopher J Lindsell
Journal:  PLoS One       Date:  2014-01-29       Impact factor: 3.240

10.  The temporal version of the pediatric sepsis biomarker risk model.

Authors:  Hector R Wong; Scott L Weiss; John S Giuliano; Mark S Wainwright; Natalie Z Cvijanovich; Neal J Thomas; Geoffrey L Allen; Nick Anas; Michael T Bigham; Mark Hall; Robert J Freishtat; Anita Sen; Keith Meyer; Paul A Checchia; Thomas P Shanley; Jeffrey Nowak; Michael Quasney; Arun Chopra; Julie C Fitzgerald; Rainer Gedeit; Sharon Banschbach; Eileen Beckman; Kelli Harmon; Patrick Lahni; Christopher J Lindsell
Journal:  PLoS One       Date:  2014-03-13       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.